Vital Farms, Inc. — Q2 2023 Form 10-Q
Reporting period: Fiscal quarter ended June 25, 2023 (13 weeks), with year-to-date comparisons for the 26 weeks ended June 25, 2023. Amounts below are in U.S. dollars; financial statement amounts are in millions unless otherwise noted.
Business context and reporting period
Vital Farms packages, markets and distributes shell eggs, egg products and butter, primarily through U.S. retail and foodservice channels. Eggs and egg-related products generated about 96% of Q2 revenue. The company sources from more than 300 family farms and describes itself as a leading U.S. pasture-raised egg brand. Fiscal 2023 is a 53-week year; the reported Q2 and prior-year comparable quarter each contained 13 weeks.
Financial performance and liquidity
| Metric | Q2 2023 | Q2 2022 | First half 2023 | First half 2022 |
|---|---|---|---|---|
| Net revenue | $106.4 | $82.9 | $225.6 | $159.9 |
| Gross profit / gross margin | $37.8 / 36% | $24.9 / 30% | $80.5 / 36% | $46.6 / 29% |
| Operating income (loss) | $8.0 | $0.7 | $18.9 | $(3.4) |
| Net income (loss) | $6.7 | $0.2 | $13.8 | $(1.3) |
| Diluted EPS | $0.15 | $0.00 | $0.32 | $(0.03) |
| Adjusted EBITDA (non-GAAP) | $11.3 | $3.7 | $25.2 | $4.2 |
Q2 revenue grew 28% year over year: management attributed $18.6 million of the increase to pricing and $5.0 million to volume. First-half revenue grew 41%, with $40.5 million from pricing and $25.2 million from volume. Management said gross-margin improvement reflected price increases implemented in 2022 and January 2023, which offset higher input and packaging costs. Q2 SG&A rose 41% to $23.9 million, mainly from marketing, employee-related and professional-service costs; shipping and distribution expense fell 19% to $5.9 million, citing freight rates and operating efficiency.
For the first half, operating cash flow was $18.9 million, versus cash used of $3.0 million a year earlier. Investing activities provided $17.0 million, largely reflecting investment-security maturities not reinvested; capital expenditures were $4.3 million. Financing activities used $1.2 million. Cash and cash equivalents were $47.7 million at June 25, 2023, and available-for-sale securities were $45.9 million, for combined cash and securities of about $93.5 million. Working capital was $120.2 million.
No revolving-credit balance was outstanding at quarter-end; the company had borrowed and repaid $7.5 million during the first half. The facility’s borrowing capacity was $20.0 million, and the company reported compliance with its covenants. On July 26, 2023, after quarter-end, the facility maturity was extended by one year to April 2, 2025. Finance lease liabilities totaled $7.8 million; the filing also reports future minimum lease payments and other contractual commitments.
Material changes versus the prior comparable period
- Profitability improved substantially: Q2 net income rose to $6.7 million from $0.2 million, and first-half results shifted from a $1.3 million net loss to $13.8 million of net income.
- Gross margin increased 6 percentage points in Q2 and 7 points for the first half, while revenue growth reflected both higher prices and increased volume.
- First-half operating cash flow improved to $18.9 million from negative $3.0 million, helped by higher earnings and margin improvement.
- Other expense increased, primarily due to commodity-derivative losses: $0.4 million in Q2 and $1.8 million in the first half. The company reported first-half derivative losses of $1.817 million.
- Inventory increased to $42.1 million from $26.8 million at December 25, 2022, including a rise in egg and egg-related inventory.
Outlook, risks, contingencies and unusual items
The filing provides no specific revenue or earnings guidance. Management said cash, securities, expected operating cash flow and available credit were expected to fund operating expenses for at least the next 12 months. It also expected adequate egg, butter, packaging and freight supply, and processing capacity, to meet anticipated demand through 2023. Management highlighted continued investment in marketing, innovation, distribution and potential production-capacity expansion.
Key risks include avian influenza, commodity and feed-price volatility, inflation and interest rates, supply-chain and freight disruption, reliance on a limited number of distributors and co-manufacturers, a sole-source shell-egg carton supplier, customer concentration, premium-price sensitivity and seasonal demand. The company disclosed HPAI outbreaks at two supplier farms, without material egg-supply disruption to date. A single customer represented 25% of revenue in both Q2 and the first half of 2023; the customer is not identified in the filing. UNFI, a distributor, also represented approximately 25% of revenue in those periods.
A consumer class action alleging false advertising remains pending; the company disputes the claims and is defending the case. Mediation was scheduled for September 2023, and the company said it could not reasonably estimate a possible loss. New commitments include approximately $8.5 million of minimum payments under a transportation agreement and $0.8 million under a warehouse infrastructure agreement. The company discontinued its ghee product line during the first half; related exit charges were described as immaterial. The convenient-breakfast exit was substantially complete in 2022, with $45,000 of liabilities remaining at quarter-end.
Important facts for investors to verify
- Whether revenue and volume growth continue, and how pricing affects demand, especially against lower-priced conventional and private-label eggs.
- Whether gross-margin gains persist as feed, commodity, packaging and other input costs change; also monitor derivative-related gains or losses.
- Customer and distributor concentration, including the unidentified customer responsible for 25% of revenue and the company’s reliance on UNFI.
- Progress on supply resilience, HPAI exposure, carton sourcing, co-manufacturer capacity and any planned processing expansion.
- Developments in the false-advertising litigation and the timing or amount of any settlement or other potential liability.
- Cash conversion, inventory levels, capital spending and compliance with credit-facility covenants; review Adjusted EBITDA alongside GAAP results because it is a non-GAAP measure.